INTEGRATED GENOMICS SHARED RESOURCE Director: Christina Harrington, Ph.D. ABSTRACT / PROJECT SUMMARY The Integrated Genomics Shared Resource (IGSR) brings together advanced sequencing, microarray, and real- time PCR technologies in an established core environment with demonstrated strengths in delivery of high- quality data and comprehensive user support. As an integrated resource for genomic technologies and expertise in the handling and processing of a wide range of RNA and DNA samples, the IGSR is able to advise Knight members on selection of genomic technology applications that best meet their research aims and then effectively support those choices. During the current funding period the IGSR has greatly expanded high-throughput sequencing resources and services, and currently provides a wide range of massively parallel sequencing (MPS) options, including exome and panel sequencing, whole genome sequencing, RNA Seq, ChIP Seq, and Methyl Seq, using an Illumina HiSeq 2500, an Illumina HiSeq 2000 upgraded for 2-lane flow cell rapid runs, and an Illumina NextSeq 500. The facility provides Knight members: 1) access to otherwise costly technology at a reasonable cost; 2) in-house consultation for project development, experimental design, and analysis of results; 3) highly standardized and quality-controlled assays and data preparation, including initial data processing and quality control; 4) rapid turnaround time for genomic services; and 5) a stable repository of sequencing and microarray data. Most importantly, the IGSR maintains a team of highly knowledgeable and experienced staff to support and deliver services and to assist researchers with project design, grant development, assay development, and research publication. The IGSR works closely with the Knight Biostatistics Shared Resource and other Knight and institutional investments in computational biology and informatics to insure accessible and secure data storage and to develop and support best practices for genomic data processing, analysis and interpretation. The IGSR will continue to work with the Knight and other OHSU stakeholders to identify and implement new technologies and assays that meet new research opportunities and evolving needs, including close collaboration with the Knight in providing tools and support needed by the new Knight early detection initiative.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA069533-22
Application #
9968100
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Lane, Ryan S; Femel, Julia; Breazeale, Alec P et al. (2018) IFN?-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. J Exp Med 215:3057-3074
Smith, Nicholas R; Swain, John R; Davies, Paige S et al. (2018) Monoclonal Antibodies Reveal Dynamic Plasticity Between Lgr5- and Bmi1-Expressing Intestinal Cell Populations. Cell Mol Gastroenterol Hepatol 6:79-96
Langer, E M; Kendsersky, N D; Daniel, C J et al. (2018) ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells. Oncogene 37:1005-1019
Sorace, Anna G; Partridge, Savannah C; Li, Xia et al. (2018) Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial. J Med Imaging (Bellingham) 5:011019
Medler, Terry R; Murugan, Dhaarini; Horton, Wesley et al. (2018) Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy. Cancer Cell 34:561-578.e6
Kelley, Katherine A; Wieghard, Nicole; Chin, Yuki et al. (2018) MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis. Dis Colon Rectum 61:1290-1296
Davare, Monika A; Henderson, Jacob J; Agarwal, Anupriya et al. (2018) Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma. Clin Cancer Res 24:6471-6482
Kurtz, Stephen E; Eide, Christopher A; Kaempf, Andy et al. (2018) Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia. Leukemia 32:2025-2028
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Watson, Spencer S; Dane, Mark; Chin, Koei et al. (2018) Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. Cell Syst 6:329-342.e6

Showing the most recent 10 out of 277 publications